Are you ready to deploy Artificial Intelligence/Machine Learning (AI/ML)?
With the release of the AI/ML Draft Guidance for Industry, the FDA has signaled acceptance of AI/ML as a tool for healthcare innovation.
Join Blue Mountain Quality Resources to explore how the agency’s AI/ML approach is transforming the regulatory compliance and asset management landscape:
- Examine the regulatory framework surrounding the AI/ML Draft Guidance for Software as a Medical Device (SaMD) submissions, in the context of the FDA’s continued emphasis on a risk-based total product lifecycle approach.
- Learn how investing in a comprehensive Predictive Change Control Plan (PCCP) could enhance future flexibility.
- Understand how AI/ML enables predictive asset and maintenance management.
- Discuss the FDA's embrace of AI/ML technology and the implications for industry advancement.
- Discover how our customers leverage these advancements to support compliance and efficiency.
Gain access to the webinar on "Harnessing the Power of AI/ML: Enhancing Regulatory Compliance and Asset Management"
Have questions? We're here to help! Please contact us by emailing us at sales@coolblue.com
Speakers
Ginny Lee
Executive Director of Global Services at Blue Mountain
